PRGO:NYE-Perrigo Company PLC (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 25.65

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.49M

Analyst Target

USD 57.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

N/A

USD 88.29B
HLN Haleon plc

N/A

USD 48.57B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 47.42B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 13.46B
CTLT Catalent Inc

N/A

USD 10.91B
ELAN Elanco Animal Health

N/A

USD 6.96B
BHC Bausch Health Companies Inc

N/A

USD 3.04B
AMRX Amneal Pharmaceuticals, Inc. C..

N/A

USD 2.54B
CPHI China Pharma Holdings Inc

N/A

USD 3.66M
YCBD cbdMD Inc

N/A

USD 1.73M

ETFs Containing PRGO

FLWR:SW 15.27 % 0.00 %

N/A

N/A
HLIT:CA Global X Lithium Producer.. 10.39 % 0.00 %

N/A

CAD 0.03B
ION Proshares S&P Global Core.. 3.98 % 0.00 %

N/A

USD 2.24M
WSRD:CA Wealthsimple Developed Ma.. 1.10 % 0.00 %

N/A

CAD 0.70B
GNRX 0.00 % 0.55 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

N/A

N/A
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

N/A

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
QDVM:F 0.00 % 0.00 %

N/A

N/A
QDVM:XETRA 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.29% 20% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.29% 20% F 17% F
Trailing 12 Months  
Capital Gain -19.72% 20% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.72% 20% F 16% F
Trailing 5 Years  
Capital Gain -54.11% 36% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -54.11% 36% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -13.00% N/A N/A 5% F
Dividend Return -10.63% N/A N/A 6% D-
Total Return 2.37% N/A N/A 51% F
Risk Return Profile  
Volatility (Standard Deviation) 8.11% N/A N/A 82% B
Risk Adjusted Return -131.12% N/A N/A N/A F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector